Medinex Limited (SGX:OTX)
Singapore · Delayed Price · Currency is SGD 0.2300
+0.0050 (2.22%)
At close: Jul 24, 2026
Medinex Financials Overview
Financials in millions SGD. Fiscal year is April - March.
Millions SGD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 12.41 | 12.41 | 12.82 | 12.59 | 12.97 | 12.04 |
Revenue Growth | -1.26% | -3.14% | 1.82% | -2.94% | 7.69% | 11.65% |
Gross Profit Gross Profit Growth | 4.68 | 4.68 | 4.73 | 4.33 | 4.22 | 4.13 |
Operating Income Operating Income Growth | 2.89 | 2.89 | 2.99 | 0.5 | 1.44 | 2.41 |
Net Income Net Income Growth | 2.22 | 2.22 | 2.83 | 1.03 | 1.7 | 2.81 |
Earnings Per Share EPS Growth | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
EPS Growth | -36.14% | -20.51% | 172.71% | -38.88% | -40.57% | -20.38% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Medical Services Medical Services Growth | 0.49 | 0.49 | 0.5 | 0.51 | 1.17 | 1.95 |
Business Support Services Business Support Services Growth | 4.59 | 4.59 | 4.59 | 4.22 | 3.99 | 2.85 |
Medical Support Services Medical Support Services Growth | 4.55 | 4.55 | 4.43 | 4.54 | 3.96 | 3.79 |
Pharmaceutical Services Pharmaceutical Services Growth | 2.79 | 2.79 | 3.29 | 3.31 | 3.84 | 3.41 |
Total Total Growth | 12.41 | 12.41 | 12.81 | 12.58 | 12.97 | 11.99 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 5.61 | 5.61 | 5.66 | 5.27 | 4.27 | 6.44 |
Total Debt Total Debt Growth | 1 | 1 | 1.67 | 2.08 | 2.34 | 3.1 |
Net Cash (Debt) Net Cash Growth | 4.61 | 4.61 | 3.99 | 3.18 | 1.93 | 3.33 |
Net Cash Growth | 25.83% | 15.48% | 25.54% | 65.01% | -42.17% | 20.24% |
Net Cash Per Share Net Cash Per Share Growth | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 | 0.03 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2.71 | 2.71 | 3.35 | 2.7 | 3.03 | 2.86 |
Capital Expenditures CapEx Growth | -0.16 | -0.16 | -0.02 | -0.03 | -0.19 | -0.2 |
Free Cash Flow Free Cash Flow Growth | 2.55 | 2.55 | 3.33 | 2.67 | 2.83 | 2.65 |
Free Cash Flow Growth | -17.08% | -23.34% | 24.75% | -5.95% | 6.90% | -10.39% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 37.72% | 37.72% | 36.90% | 34.42% | 32.53% | 34.27% |
Operating Margin | 23.28% | 23.28% | 23.34% | 3.99% | 11.10% | 20.03% |
Pretax Margin | 19.50% | 19.50% | 23.28% | 8.07% | 15.76% | 27.12% |
Profit Margin | 17.92% | 17.92% | 22.12% | 8.21% | 13.11% | 23.31% |
FCF Margin | 20.54% | 20.54% | 25.95% | 21.18% | 21.86% | 22.02% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.017 | 0.017 | 0.017 | 0.017 | 0.017 | 0.017 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 7.30% | 7.47% | 9.50% | 10.41% | 11.02% | 9.58% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 13.78 | 13.61 | 8.89 | 24.14 | 15.22 | 11.22 |
P/FCF Ratio | 12.14 | 11.87 | 7.58 | 9.36 | 9.13 | 11.87 |
PS Ratio | 2.49 | 2.44 | 1.97 | 1.98 | 2.00 | 2.62 |